The outbreak of the novel coronavirus disease (COVID‐19) quickly spread all over China
and to more than 20 other countries. Although the virus (severe acute respiratory syndrome …

Abstract Coronavirus disease (COVID‐19), caused by a novel betacoronavirus, severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has rapidly developed into a …

Objectives SARS-CoV-2 infection diagnosis is challenging in patients from 2 to 3 weeks after
the onset of symptoms, due to the low positivity rate of the PCR. Serologic tests could be …

The serological testing of anti‐SARS‐CoV‐2 immunoglobulin G (IgG) and/or IgM is widely
used in the diagnosis of COVID‐19. However, its diagnostic efficacy remains unclear. In this …

Since December 2019 the novel coronavirus SARS-CoV-2 has emerged as the cause of a
pandemic disease known as coronavirus disease 19 (COVID-19). 1 On February 21th 2020 …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
coronavirus disease 2019 (COVID-19) epidemic in China, December 2019. The clinical …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) serological assays are
urgently needed for rapid diagnosis, contact tracing, and for epidemiological studies. So far …

Background The emergence of new SARS-CoV-2 has promoted the development of new
serological tests that could be complementary to RT-PCR. Nevertheless, the assessment of …

The quantitative range and reproducibility of current serological tests for severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) are not optimized. Herein, we developed …

An outbreak of new coronavirus SARS-CoV-2 was occurred in Wuhan, China and rapidly
spread to other cities and nations. The standard diagnostic approach that widely adopted in …